Winfried Kern to Betacoronavirus
This is a "connection" page, showing publications Winfried Kern has written about Betacoronavirus.
Connection Strength
0.078
-
[COVID-19-Response - Strategies of the Task-Force Coronavirus and experiences upon implementation in the management of 115 cases at the University Medical Center Freiburg]. Dtsch Med Wochenschr. 2020 05; 145(10):657-664.
Score: 0.037
-
Covid-19 in patients with hematological and solid cancers at a Comprehensive Cancer Center in Germany. Cancer Med. 2020 11; 9(22):8412-8422.
Score: 0.010
-
COVID-19 in a Severely Immunosuppressed Patient With Life-Threatening Eosinophilic Granulomatosis With Polyangiitis. Front Immunol. 2020; 11:2086.
Score: 0.010
-
A prospective, randomised, double blind placebo-controlled trial to evaluate the efficacy and safety of tocilizumab in patients with severe COVID-19 pneumonia (TOC-COVID): A structured summary of a study protocol for a randomised controlled trial. Trials. 2020 Jun 03; 21(1):470.
Score: 0.009
-
Anosmia in COVID-19 patients. Clin Microbiol Infect. 2020 10; 26(10):1426-1427.
Score: 0.009
-
COVID-19 in-hospital mortality and mode of death in a dynamic and non-restricted tertiary care model in Germany. PLoS One. 2020; 15(11):e0242127.
Score: 0.002